The $65.6 Billion Secret Wall Street Doesn't Want You to Know About Cardinal Health24/7 Wall Street • 02/05/26
Compared to Estimates, Cardinal (CAH) Q2 Earnings: A Look at Key MetricsZacks Investment Research • 02/05/26
Cardinal Health boosts annual profit forecast banking on surging demand for specialty drugsReuters • 02/05/26
Cardinal Health Reports Second Quarter Fiscal Year 2026 Results and Raises OutlookPRNewsWire • 02/05/26
Pharma, Specialty Units Likely to Drive Cardinal Health's Q2 EarningsZacks Investment Research • 02/04/26
Cardinal (CAH) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance MeasuresZacks Investment Research • 02/02/26
4 Defensive Stocks to Buy as Consumer Confidence Dips to12-Year LowZacks Investment Research • 02/02/26
5 Broker-Loved Stocks to Watch Amid Steady Start to Q4 Earnings SeasonZacks Investment Research • 01/29/26
Cardinal Health (CAH) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseZacks Investment Research • 01/29/26
Cardinal Health Upgraded As It Maintains Investment-Grade Status And Position In RadiopharmaceuticalsSeeking Alpha • 01/23/26
Amazon & 3 More Stocks With Strong Interest Coverage Worth BuyingZacks Investment Research • 01/16/26
Will Cardinal (CAH) Beat Estimates Again in Its Next Earnings Report?Zacks Investment Research • 01/15/26
5 Broker-Friendly Stocks to Keep an Eye on as Inflation Concerns EaseZacks Investment Research • 01/15/26
Cardinal Health, Inc. (CAH) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/13/26
Cardinal Health Raises Fiscal 2026 Outlook and Highlights Strategic Progress During J.P. Morgan Healthcare Conference PresentationPRNewsWire • 01/13/26